JPRN-UMIN000020591已完成1 期
A phase I clinical trial evaluating the safety of allogeneic Adipose Tissue-derived multilineage progenitor cells-transplantation therapy in severe familial hypercholesterolemia patients - A phase I clinical trial evaluating the safety of allogeneic Adipose Tissue-derived multilineage progenitor cells-transplantation therapy in severe familial hypercholesterolemia patients
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patients corresponding to any of the following criteria are excluded from the study. 1) The patients who have or are suspected to have a malignant tumor or a precancerous lesion; or have the past history of those within five years 2) The patients who have a coronary disease or cerebrovascular disorder, which require any treatment. 3) The patients who have renal dysfunction, liver dysfunction and blood disorders. 4) The patient who have diabetes mellitus or have more than 6.5% HbA1c. 5) The patient who have an active infectious disease. 6) The patient who have any of infectious disease such as HBV (carrier and the existing infected patient), HCV, HTLV-I (ATLA), HIV, parvoviral B19, Treponema pallidum, gonococcus, tuberculosis, cytomegalovirus, EB virus, one of waist e viruses. 7) The patient who requires to have any treatment (surgical care) affecting the liver function test during the study 8) The patient Person with the communicable spongy encephalopathic and doubt and dementia 9) The pregnant patient, the possible pregnant patient or the patient who wishes to have pregnancy during a study 10) The patient who gives breast-feeding 11) The patient who has the past of an alcoholism or the drug dependency within six months before registration 12) The patient who are diagnosed by the doctor operating this study not to be able to recognize the significance of the clinical study from a mental disease. 13) Others, the patient who are diagnosed not to be eligible to be enrolled into this study by the doctor.
研究者
相似试验
已完成
1 期
A trial to test the safety of a herbal formulatioCTRI/2018/02/011689SK Biolabs100
已完成
1 期
A trial to test the safety of a herbal drug.CTRI/2017/11/010617SK Biolabs100
已完成
1 期
A clinical trial to test the safety of a drugCTRI/2017/11/010540SK Biolabs100
已完成
1 期
A trial to test the safety of a drugCTRI/2017/12/010788SK Biolabs100
已完成
1 期
A trial to test the safety of a drug.CTRI/2017/11/010680SK Biolabs100